{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Asheville",
      "state": "NC",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80601",
      "recalling_firm": "King Bio Inc.",
      "address_1": "3 Westside Dr",
      "address_2": "N/A",
      "postal_code": "28806-2846",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.",
      "recall_number": "D-0739-2019",
      "product_description": "Dr. King's SafeCare Rx LymePlex, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006923, NDC 57955-0069-2",
      "product_quantity": "95 bottles",
      "reason_for_recall": "Microbial contamination",
      "recall_initiation_date": "20180720",
      "center_classification_date": "20190308",
      "termination_date": "20220119",
      "report_date": "20190320",
      "code_info": "Lots: 072815F Exp. 07/18; 061716C Exp. 06/19; 020817D Exp. 02/20; 030518F Exp. 03/20"
    }
  ]
}